
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Cell Dev. Biol. , 17 November 2022
Sec. Signaling
Volume 10 - 2022 | https://doi.org/10.3389/fcell.2022.1090025
This article is a correction to:
Long Non-Coding RNAs as Molecular Biomarkers in Cholangiocarcinoma
A Corrigendum on
Long non-coding RNAs as molecular biomarkers in cholangiocarcinoma
by Wu Y, Hayat K, Hu Y and Yang J (2022). Front. Cell Dev. Biol. 10:890605. doi: 10.3389/fcell.2022.890605
In the published article, there was an error in Affiliation 1. Instead of “The Fourth Clinical College of Zhejiang Chinese Medicine University,” it should be “The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: cholangiocarcinoma, lncRNA, biomarker, diagnosis, prognosis, therapeutic target
Citation: Wu Y, Hayat K, Hu Y and Yang J (2022) Corrigendum: Long non-coding RNAs as molecular biomarkers in cholangiocarcinoma. Front. Cell Dev. Biol. 10:1090025. doi: 10.3389/fcell.2022.1090025
Received: 04 November 2022; Accepted: 07 November 2022;
Published: 17 November 2022.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2022 Wu, Hayat, Hu and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jianfeng Yang, eWpmMzMwM0B6anUuZWR1LmNu
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.